Doximity (DOCS): Taking Stock of Valuation After Analyst Upgrades on AI Tools and Growth Outlook [Yahoo! Finance]
Doximity, Inc. Class A (DOCS)
Company Research
Source: Yahoo! Finance
clinicians daily routines, and an appealing valuation after a sharp stock pullback. See our latest analysis for Doximity. After a steep 90 day share price return of minus 38.05 percent from earlier policy jitters, Doximity now trades around 44.65 dollars, with one year total shareholder return of minus 16.2 percent but a still impressive three year total shareholder return of 32.3 percent. This suggests that longer term momentum remains intact even as sentiment rebuilds. If this healthcare platform story has your attention, it might be a good time to scout other potential winners among healthcare stocks and see what else is setting up for a recovery. With shares trading at a steep discount to Wall Street targets despite rising AI adoption and upgraded growth forecasts, investors face a pivotal question: is Doximity genuinely undervalued here or already reflecting its next leg of expansion? With the most popular narrative placing Doximity's fair value well above the recent 44
Show less
Read more
Impact Snapshot
Event Time:
DOCS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DOCS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DOCS alerts
High impacting Doximity, Inc. Class A news events
Weekly update
A roundup of the hottest topics
DOCS
News
- Doximity (NASDAQ:DOCS) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating.MarketBeat
- Doximity (NYSE:DOCS) is now covered by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>. They set a "hold (c+)" rating on the stock.MarketBeat
- Doximity (NYSE:DOCS) was upgraded by analysts at Barclays PLC to a "strong-buy" rating.MarketBeat
- Doximity (NYSE:DOCS) was upgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=DOCS&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> froMarketBeat
- The Greatest Value From AI Scribes May Come From Influencing Decisions, Not Documenting Them [Forbes]Forbes
DOCS
Earnings
- 11/6/25 - Beat
DOCS
Sec Filings
- 12/3/25 - Form 4
- 12/1/25 - Form 144
- 11/24/25 - Form 4
- DOCS's page on the SEC website